Canadian β-lactamase-negative Haemophilus influenzae isolates showing decreased susceptibility toward ampicillin have significant penicillin binding protein 3 mutations

Diagnostic Microbiology and Infectious Disease

Volumn 63, Issue 4, 2009, Pages 379-383

  Shuel, Michelle L ^a   Tsang, Raymond S W ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

BLNAR; BLPACR; Canada; H. influenzae

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFACLOR; CEFTRIAXONE; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 3; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CANADA; CHILD; DRUG SENSITIVITY; FEMALE; GENE MUTATION; HAEMOPHILUS INFLUENZAE; HOST SUSCEPTIBILITY; HUMAN; HUMAN EXPERIMENT; INFANT; MALE; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ADOLESCENT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; AMPICILLIN; AMPICILLIN RESISTANCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CANADA; CHILD, PRESCHOOL; DNA, BACTERIAL; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTATION, MISSENSE; PENICILLIN-BINDING PROTEINS;

EID: 62249136309     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.12.015     Document Type: Article

References (21)

1. Andrews J.M., and and the BSAC Working Party on Susceptibility Testing. BSAC standardized disc susceptibility testing method (version 6). J. Antimicrob. Chemother. 60 (2007) 20-41
2. Barry A.L., Fuchs P.C., and Brown S.D. Identification of β-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight media. Antimicrob. Agents Chemother. 45 (2001) 1585-1588
3. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement, M100-S18 (2008), CLSI, Wayne, PA
4. Dabernat H., Delmas C., Seguy M., Pelissier R., Faucon G., Bennamani S., and Pasquier C. Diversity of β-lactam resistance-conferrning amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob. Agents Chemother. 46 (2002) 2208-2218
5. Doern G.V., Brueggemann A.B., Pierce G., Holley Jr. H.P., and Rauch A. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob. Agents Chemother. 41 (1997) 292-297
6. Falla T.J., Crook D.W., Brophy L.N., Maskell D., Kroll J.S., and Moxon E.R. PCR for capsule typing of Haemophilus influenzae. J. Clin. Microbiol. 32 (1994) 2382-2386
7. Fleischmann R.D., Adams M.D., White O., Clayton R.A., Kirkness E.F., Kerlavage A.R., Bult C.J., Tomb J., Dougherty B.A., Merrick J.M., McKenny K., Sutton G.G., FitzHugh W., Fields C.A., Gocayne J.D., Scott J.D., Shirley R., Liu L.I., Glodek A., Kelley J.M., Weidman J.F., Phillips C.A., Spriggs T., Hedblom E., Cotton M.D., Utterback T., Hanna M.C., Nguyen D.T., Saudek D.M., Brandon R.C., Fine L.D., Fritchman J.L., Fuhrman J.L., Geoghagen N.S., Gnehm C.L., McDonald L.A., Small K.V., Fraser C.M., Smith H.O., and Venter J.C. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269 (1995) 496-512
8. Garcia-Cobos S., Campos J., Lazaro E., Roman F., Cercenado E., Garcia-Rey C., Perez-Vazquez M., Oteo J., and de Abajo F. Ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Antimicrob. Agents Chemother. 51 (2007) 2564-2573
9. Garcia-de-Lomas J., Lerma M., Cebrian L., Juan-Baron J.L., Coronel P., Gimenez M.J., and Aguilar L. Influence of Haemophilus influenzae β-lactamase production and/or ftsI gene mutations on in vitro activity of and susceptibility rates to aminopenicillins and second- and third-generation cephalosporins. Int. J. Antimicrob. Agents 30 (2007) 190-192
10. Hasegawa K., Chiba N., Kobayashi R., Murayama S.Y., Iwata S., Sunakawa K., and Ubukata K. Rapidly increasing prevalence of a β-lactamase-non-producing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis. Antimicrob. Agents Chemother. 48 (2004) 1509-1514
11. Hasegawa K., Kobayashi R., Takada E., Ono A., Chiba N., Morozumi M., Iwata S., Sunakawa K., Ubukata K., and on behalf of the Working Group of the Nationwide Surveillance for Bacterial Meningitis. High prevalence of type b β-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced. J. Antimicrob. Chemother 57 (2006) 1077-1082
12. Karlowsky J.A., Critchley I.A., Blosser-Middleton R.S., Karginova E.A., Jones M.E., Thornsberry C., and Sahm D.F. Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a β-lactamase-negative and ampicillin-resistant strain. J. Clin. Microbiol. 40 (2002) 1063-1066
13. Karpanoja P., Nissinen A., Huovinen P., Sarkkinen H., and on behalf of the Finnish Study Group for Antimicrobial Resistance. Disc diffusion susceptibility testing of Haemophilus influenzae by NCCLS methodology using low-strength ampicillin and co-amoxiclav disc. J. Antimicrob. Chemother. 53 (2004) 660-663
14. Kim I.S., Ki C.S., Kim S., Oh W.S., Peck K.R., Song J.H., Lee K., and Lee N.Y. Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea. Antimicrob. Agents Chemother. 51 (2007) 453-460
15. Meats E., Feil E.J., Stringer S., Cody A.J., Goldstein R., Kroll J.S., Popovic T., and Spratt B.G. Characterization of encapsulated and non-encapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. J. Clin. Microbiol. 41 (2003) 1623-1636
16. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin. Microbiol. Rev. 13 (2000) 302-317
17. Scriver S.R., Low D.E., Simor A.E., Toye B., McGeer A., Jaeger R., and Canadian Haemophilus Group. Broth microdilution testing of Haemophilus influenzae with Haemophilus test medium versus lysed horse blood. J. Clin. Microbiol 30 (1992) 2284-2289
18. Scriver S.R., Walmsley S.L., Kau C.L., Hoban D.J., Brunton J., McGeer A., Moore T.C., Witwicki, Canadian Haemophilus Study Group, and Low D.E. Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their β-lactamases. Antimicrob. Agents Chemother. 38 (1994) 1678-1680
19. Sill M., and Tsang R. Antibiotic susceptibility of invasive Haemophilus influenzae strains in Canada. Antimicrob. Agents Chemother. 52 (2008) 1551-1552
20. Ubukata K., Shibasaki Y., Yamamoto K., Chiba N., Hasegawa K., Takeuchi Y., Sunakawa K., Inoue M., and Konno M. Association of amino acid substitutions in penicillin-binding protein 3 with β-lactam resistance in β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob. Agents Chemother. 45 (2001) 1693-1699
21. Zhanel G.G., Palatnick L., Nichol K.A., Low D.E., Hoban D.J., and CROSS study Group. Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob. Agents Chemother. 47 (2003) 1875-1881